Investing Profile

Tom Mather

InvestorAdvisorVC
Investing in Emerging Ophthalmic Technologies
ophthafund.com/team/tom-mathe...Charleston, South Carolina
Photo of Tom Mather, Managing Partner at OphthaFund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
OphthaFund Managing Partner
$100K - $5.0M
$1M
5
CompanyStageDateRound SizeTotal Raised
MCAL Therapeutics
SeedAug 2022
Premark Pharma
Series AMar 2019
blinktbi
SeedJan 2018
Allysta Pharmaceuticals
SeedAug 2017
Encore Vision
SeedJun 2010